XELJANZ XR FDA approval date
The FDA approved XELJANZ XR on 23 Feb 2016.
- FDA approval date
- 23 Feb 2016
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as TOFACITINIB CITRATE
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2016-02-23Day | XELJANZ XR | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA208246", "applicant_as_listed_by_fda": "PFIZER", "brand_names": ["XELJANZ XR"], "active_ingredients": ["TOFACITINIB CITRATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20160223", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |